In APP/PS1 mice, both TLR4 and TREM2 are elevated at the protein level [185]; the treatment of these mice with LPS, a ligand for TLR4, resulted in worsened cognitive impairment in these mice, suggesting that superimposition of systemic inflammation due to bacterial infection could speed up the AD progression. Here, TREM2 is linked to bacterial infectious disease.